2017 Annual Meeting

SYM028 - SYMPOSIUM 28: Great Debates in Pulmonary Hypertension

Apr 7, 2017 1:30pm ‐ Apr 7, 2017 3:30pm


Description

Case Presentation: To Treat or Not To Treat...Interstitial Lung Disease (IDL)-PH
Christopher King, MD, FACP, FCCP

DEBATE (PRO): Pulmonary Hypertension Due to Lung Disease Should Be Treated with PAH Specific Therapies
Steven Nathan, MD

DEBATE (CON): Pulmonary Hypertension Due to Lung Disease Should Be Treated with PAH Specific Therapies
Marius Hoeper, MD

Case Presentation: To Treat or Not To Treat...Borderline PAH
Kurt Prins, MD, PhD

DEBATE (PRO): “Borderline” PAH Should Be Treated with PAH Specific Therapy
Bradley Maron, MD

DEBATE (CON): “Borderline” PAH Should Be Treated with PAH Specific Therapy
Jean-Luc Vachiery, MD

Case Presentation: "I'm doing fine Doc, do I really need another pill?"
Roberto Badagliacca, MD

DEBATE (PRO): My Patient with PAH is Clinically Stable on Monotherapy: I Should Escalate to Dual or Triple Therapy
Rogerio Souza, MD

DEBATE (CON): My Patient with PAH is Clinically Stable on Monotherapy: I Should Escalate to Dual or Triple Therapy
Veronica Franco, MD

Speaker(s):

Tags: PH ALL

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
* - Indicates answer is required.
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content